Quarter

Peloton has continued to lose money as more people ditch their pandemic-era workout routines as stay-at-home orders are lifted around the world

Pandemic darling Peloton’s stocks plunge 18% as it reveals it lost staggering $750M in last quarter

Pandemic darling Peloton’s stocks have plummeted nearly 90 percent over the past year, as company executives revealed on Tuesday that it lost a staggering $750 million in the last quarter due to unsold inventory and mounting costs.  The company lost $757.1 million for the three months of 2022, amounting to about $2.27 per share. And when …

Pandemic darling Peloton’s stocks plunge 18% as it reveals it lost staggering $750M in last quarter Read More »

Roblox Reports First Quarter 2022 Financial Results

Roblox Reports First Quarter 2022 Financial Results

Revenue up 39% over prior year up to $537.1 million Strong year over year growth in Daily Active Users and Hours Engaged, up 28% and 22%, respectively SAN MATEO, Calif., May 10, 2022–(BUSINESS WIRE)–Roblox Corporation (NYSE: RBLX), a global platform bringing millions of people together through shared experiences, released its first quarter 2022 financial results …

Roblox Reports First Quarter 2022 Financial Results Read More »

SoFi Technologies, Inc. Reports First Quarter 2022 Results

SoFi Technologies, Inc. Reports First Quarter 2022 Results

SAN FRANCISCO–(BUSINESS WIRE)–SoFi Technologies, Inc. (NASDAQ: SOFI), a member-centric, one-stop shop for digital financial services that helps members borrow, save, spend, invest and protect their money, reported financial results today for its first quarter ended March 31, 2022. “We delivered another quarter of great results, with record adjusted net revenue up 49% year-over-year, a seventh …

SoFi Technologies, Inc. Reports First Quarter 2022 Results Read More »

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights

Achieved revenue of $704 million and net income of $203 million highlighting the first profitable quarter as a commercial stage company Reiterating full year 2022 total revenue guidance of between $4 and $5 billion Continued label expansion including primary, booster and adolescent authorizations and new shipments of Nuvaxovid™ into European Union, Canada, South Korea, Australia …

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights Read More »